首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Adjuvant rhubarb alleviates organs dysfunction and inhibits inflammation in heat stroke
【2h】

Adjuvant rhubarb alleviates organs dysfunction and inhibits inflammation in heat stroke

机译:大黄佐剂可缓解器官功能障碍并抑制中暑炎症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The aim of the present study was to investigate the effects of adjuvant rhubarb on the recovery of patients with heat stroke. A total of 85 patients with heat stroke were randomly assigned to two treatment groups: One group receiving conventional treatment for heat stroke (conventional group) and one group receiving rhubarb supplement in addition to conventional treatment (rhubarb group). Liver and kidney function parameters, Acute Physiology and Chronic Health Evaluation (APACHE) II scores, plasma interleukin-6 (IL-6), procalcitonin (PCT), C-reactive protein (CRP) levels and venous white blood cell count (WBC) were analyzed. The length of stay in the intensive care units (ICUs) and hospital were recorded. Kaplan-Meier curves were drawn to determine the 30-day survival of the patients. The results indicated that rhubarb supplementation significantly reduced the WBC, as well as CRP, PCT and IL-6 levels at treatment days 3-5. Furthermore, rhubarb intake was observed to limit heat stroke-induced damage to liver and kidney function by decreasing the abnormally high levels of plasma aspartate aminotransferase, alanine aminotransferase and creatinine. Finally, patients in the rhubarb group had shorter ICU and hospital stays as well as a lower APACHE II score than those in the conventional group. However, no significant difference in the 30-day mortality rate was observed between the two groups. In conclusion, rhubarb intake provided a significant benefit for patients with heat stroke by inhibiting systemic inflammation and mitigating liver and kidney injury.
机译:本研究的目的是研究大黄佐剂对中暑患者康复的影响。总共将85名中暑患者随机分为两个治疗组:一组接受中暑常规治疗(常规组),除常规治疗外还接受大黄补充剂的一组(大黄组)。肝肾功能参数,急性生理和慢性健康评估(APACHE)II评分,血浆白介素6(IL-6),降钙素原(PCT),C反应蛋白(CRP)水平和静脉白细胞计数(WBC)被分析。记录在重症监护病房(ICU)和医院的住院时间。绘制Kaplan-Meier曲线以确定患者的30天存活率。结果表明,大黄补充剂在治疗第3-5天显着降低了WBC以及CRP,PCT和IL-6的水平。此外,观察到大黄的摄入可通过降低异常高水平的血浆天冬氨酸转氨酶,丙氨酸转氨酶和肌酐来限制中暑诱导的肝和肾功能损害。最后,与传统组相比,大黄组患者的ICU和住院时间较短,APACHE II评分较低。但是,两组之间的30天死亡率没有显着差异。总之,大黄的摄入通过抑制系统性炎症并减轻肝肾损害,为中暑患者提供了显着的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号